Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
8.49
-0.05 (-0.59%)
At close: Dec 20, 2024, 4:00 PM
8.40
-0.09 (-1.06%)
After-hours: Dec 20, 2024, 4:34 PM EST
Zevra Therapeutics Market Cap
Zevra Therapeutics has a market cap or net worth of $453.16 million as of December 20, 2024. Its market cap has increased by 143.37% in one year.
Market Cap
453.16M
Enterprise Value
423.71M
1-Year Change
143.37%
Ranking
Category
Stock Price
$8.49
Market Cap Chart
Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $453.16M, an increase of 228.85%. That is a compound annual growth rate of 13.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 453.20M | 91.06% |
| Dec 29, 2023 | 237.20M | 49.75% |
| Dec 30, 2022 | 158.40M | -48.50% |
| Dec 31, 2021 | 307.60M | 505.51% |
| Dec 31, 2020 | 50.80M | 303.17% |
| Dec 31, 2019 | 12.60M | -73.25% |
| Dec 31, 2018 | 47.10M | -20.71% |
| Dec 29, 2017 | 59.40M | 37.50% |
| Dec 30, 2016 | 43.20M | -84.95% |
| Dec 31, 2015 | 287.00M | 108.27% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InnovAge Holding | 478.16M |
| Alumis | 469.54M |
| Ginkgo Bioworks Holdings | 463.94M |
| AnaptysBio | 456.43M |
| MeiraGTx Holdings | 456.42M |
| Kodiak Sciences | 455.71M |
| UroGen Pharma | 451.96M |
| Celcuity | 445.55M |